Induction of intrauterine growth restriction by reducing placental vascular growth with the angioinhibin TNP-470

CS Rutland, M Mukhopadhyay, S Underwood, N Clyde, TM Mayhew, Christopher Mitchell

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The placenta is a specialized vascular interface between the maternal and fetal circulations that increases in size to accommodate the nutritional and metabolic demands of the growing fetus. Vascular proliferation and expansion are critical components of placental development and, consequently, interference with vascular growth has the potential to severely restrict concurrent development of both the placenta and fetus. In this study, we describe the effects of an antiangiogenic agent, TNP-470, on placental vascular development and the induction of a form of intrauterine growth restriction (IUGR) in mice. Administration of TNP-470 to dams in the second half of pregnancy resulted in a smaller maternal weight gain accompanied by decreased placental and fetal sizes in comparison with control animals. Total numbers of fetuses per litter were not affected significantly. Stereological analysis of placentas revealed no changes in the combined lengths of vessels. However, the mean cross-sectional areas of maternal and fetal vessels in the labyrinth of TNP-470-treated mice were reduced at Embryonic Day 13.5 (E13.5) but not at E18.5. Further analysis showed reduced placental endothelial proliferation at E13.5 and E18.5 in TNP-470-treated animals. No other structural or morphometric differences in placentas were detected between TN P-470-treated and control mice at E18.5. This study provides conclusive evidence that administration of TNP-470 interferes with placental vascular proliferation and vessel caliber and results in a reproducible model of IUGR.
LanguageEnglish
Pages1164-1173
JournalBiology of Reproduction
Volume73
Issue number6
DOIs
Publication statusPublished - Dec 2005

Fingerprint

Blood Vessels
Placenta
Growth
Placentation
Fetus
Mothers
Angiogenesis Inhibitors
Inner Ear
Weight Gain
O-(chloroacetylcarbamoyl)fumagillol
Pregnancy

Cite this

Rutland, CS ; Mukhopadhyay, M ; Underwood, S ; Clyde, N ; Mayhew, TM ; Mitchell, Christopher. / Induction of intrauterine growth restriction by reducing placental vascular growth with the angioinhibin TNP-470. In: Biology of Reproduction. 2005 ; Vol. 73, No. 6. pp. 1164-1173.
@article{3682abb96bc3428cb7b1b9688103b1eb,
title = "Induction of intrauterine growth restriction by reducing placental vascular growth with the angioinhibin TNP-470",
abstract = "The placenta is a specialized vascular interface between the maternal and fetal circulations that increases in size to accommodate the nutritional and metabolic demands of the growing fetus. Vascular proliferation and expansion are critical components of placental development and, consequently, interference with vascular growth has the potential to severely restrict concurrent development of both the placenta and fetus. In this study, we describe the effects of an antiangiogenic agent, TNP-470, on placental vascular development and the induction of a form of intrauterine growth restriction (IUGR) in mice. Administration of TNP-470 to dams in the second half of pregnancy resulted in a smaller maternal weight gain accompanied by decreased placental and fetal sizes in comparison with control animals. Total numbers of fetuses per litter were not affected significantly. Stereological analysis of placentas revealed no changes in the combined lengths of vessels. However, the mean cross-sectional areas of maternal and fetal vessels in the labyrinth of TNP-470-treated mice were reduced at Embryonic Day 13.5 (E13.5) but not at E18.5. Further analysis showed reduced placental endothelial proliferation at E13.5 and E18.5 in TNP-470-treated animals. No other structural or morphometric differences in placentas were detected between TN P-470-treated and control mice at E18.5. This study provides conclusive evidence that administration of TNP-470 interferes with placental vascular proliferation and vessel caliber and results in a reproducible model of IUGR.",
author = "CS Rutland and M Mukhopadhyay and S Underwood and N Clyde and TM Mayhew and Christopher Mitchell",
year = "2005",
month = "12",
doi = "10.1095/biolreprod.105.043893",
language = "English",
volume = "73",
pages = "1164--1173",
journal = "Biology of Reproduction",
issn = "0006-3363",
number = "6",

}

Induction of intrauterine growth restriction by reducing placental vascular growth with the angioinhibin TNP-470. / Rutland, CS; Mukhopadhyay, M; Underwood, S; Clyde, N; Mayhew, TM; Mitchell, Christopher.

In: Biology of Reproduction, Vol. 73, No. 6, 12.2005, p. 1164-1173.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Induction of intrauterine growth restriction by reducing placental vascular growth with the angioinhibin TNP-470

AU - Rutland, CS

AU - Mukhopadhyay, M

AU - Underwood, S

AU - Clyde, N

AU - Mayhew, TM

AU - Mitchell, Christopher

PY - 2005/12

Y1 - 2005/12

N2 - The placenta is a specialized vascular interface between the maternal and fetal circulations that increases in size to accommodate the nutritional and metabolic demands of the growing fetus. Vascular proliferation and expansion are critical components of placental development and, consequently, interference with vascular growth has the potential to severely restrict concurrent development of both the placenta and fetus. In this study, we describe the effects of an antiangiogenic agent, TNP-470, on placental vascular development and the induction of a form of intrauterine growth restriction (IUGR) in mice. Administration of TNP-470 to dams in the second half of pregnancy resulted in a smaller maternal weight gain accompanied by decreased placental and fetal sizes in comparison with control animals. Total numbers of fetuses per litter were not affected significantly. Stereological analysis of placentas revealed no changes in the combined lengths of vessels. However, the mean cross-sectional areas of maternal and fetal vessels in the labyrinth of TNP-470-treated mice were reduced at Embryonic Day 13.5 (E13.5) but not at E18.5. Further analysis showed reduced placental endothelial proliferation at E13.5 and E18.5 in TNP-470-treated animals. No other structural or morphometric differences in placentas were detected between TN P-470-treated and control mice at E18.5. This study provides conclusive evidence that administration of TNP-470 interferes with placental vascular proliferation and vessel caliber and results in a reproducible model of IUGR.

AB - The placenta is a specialized vascular interface between the maternal and fetal circulations that increases in size to accommodate the nutritional and metabolic demands of the growing fetus. Vascular proliferation and expansion are critical components of placental development and, consequently, interference with vascular growth has the potential to severely restrict concurrent development of both the placenta and fetus. In this study, we describe the effects of an antiangiogenic agent, TNP-470, on placental vascular development and the induction of a form of intrauterine growth restriction (IUGR) in mice. Administration of TNP-470 to dams in the second half of pregnancy resulted in a smaller maternal weight gain accompanied by decreased placental and fetal sizes in comparison with control animals. Total numbers of fetuses per litter were not affected significantly. Stereological analysis of placentas revealed no changes in the combined lengths of vessels. However, the mean cross-sectional areas of maternal and fetal vessels in the labyrinth of TNP-470-treated mice were reduced at Embryonic Day 13.5 (E13.5) but not at E18.5. Further analysis showed reduced placental endothelial proliferation at E13.5 and E18.5 in TNP-470-treated animals. No other structural or morphometric differences in placentas were detected between TN P-470-treated and control mice at E18.5. This study provides conclusive evidence that administration of TNP-470 interferes with placental vascular proliferation and vessel caliber and results in a reproducible model of IUGR.

U2 - 10.1095/biolreprod.105.043893

DO - 10.1095/biolreprod.105.043893

M3 - Article

VL - 73

SP - 1164

EP - 1173

JO - Biology of Reproduction

T2 - Biology of Reproduction

JF - Biology of Reproduction

SN - 0006-3363

IS - 6

ER -